Table S1 from Camrelizumab Plus Famitinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: Data from an Open-label, Multicenter Phase II Basket Study

Yuanyuan Qu,Hailiang Zhang, Guo H,Hong Luo,Qing Zou,Nianzeng Xing,Shujie Xia,Zhongquan Sun,Xuepei Zhang, Chao‐Hong He, Jianguo Cai, Xiao Zhang,Quanren Wang,Dingwei Ye

openalex（2023）

Cited 0|Views1
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined